NDC 43742-1527 Virus Combination

Influenzinum (2018-2019),Herpes Simplex 1 Nosode,Herpes Simplex 2 Nosode,Human Herpesvirus - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
43742-1527
Proprietary Name:
Virus Combination
Non-Proprietary Name: [1]
Influenzinum (2018-2019), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6a, Human Herpesvirus 6b, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-barr Virus Nosode
Substance Name: [2]
Hepatitis B Virus; Human Adenovirus B Serotype 7 Strain 55142 Antigen; Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Human Herpesvirus 1; Human Herpesvirus 2; Human Herpesvirus 4; Human Herpesvirus 5; Human Herpesvirus 6; Influenza A Virus A/singapore/gp1908/2015 Ivr-180 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/singapore/infimh-16-0019/2016 Nib-104 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/maryland/15/2016 Antigen (formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated)
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s): [4]
  • Oral - Administration to or by way of the mouth.
  • Labeler Name: [5]
    Deseret Biologicals, Inc.
    Labeler Code:
    43742
    Marketing Category: [8]
    UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
    Start Marketing Date: [9]
    08-21-2019
    End Marketing Date: [10]
    07-10-2025
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 43742-1527-1

    Package Description: 30 mL in 1 BOTTLE, DROPPER

    Product Details

    What is NDC 43742-1527?

    The NDC code 43742-1527 is assigned by the FDA to the product Virus Combination which is a human over the counter drug product labeled by Deseret Biologicals, Inc.. The generic name of Virus Combination is influenzinum (2018-2019), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode. The product's dosage form is liquid and is administered via oral form. The product is distributed in a single package with assigned NDC code 43742-1527-1 30 ml in 1 bottle, dropper . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Virus Combination?

    For temporary relief of symptoms related to general viral infection (such as influenza, Epstein-Barr virus [EBV], cytomegalovirus [CMV], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.****These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration. For temporary relief of symptoms related to general viral infection (such as influenza, Epstein-Barr virus [EBV], cytomegalovirus [CMV], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.****These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.

    What are Virus Combination Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    Which are Virus Combination UNII Codes?

    The UNII codes for the active ingredients in this product are:

    • INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: Q3P251C5MT)
    • INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: LD80H821HF) (Active Moiety)
    • INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: 2ZSC17SIJ6)
    • INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: 1R31M8U8H9) (Active Moiety)
    • INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: 8V4458342X)
    • INFLUENZA B VIRUS B/MARYLAND/15/2016 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: OES3CXI7E9) (Active Moiety)
    • INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: B93BQX9789)
    • INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: 9HB0XUS9TM) (Active Moiety)
    • HUMAN HERPESVIRUS 1 (UNII: 22G38P19RL)
    • HUMAN HERPESVIRUS 1 (UNII: 22G38P19RL) (Active Moiety)
    • HUMAN HERPESVIRUS 2 (UNII: 74J6DNH49U)
    • HUMAN HERPESVIRUS 2 (UNII: 74J6DNH49U) (Active Moiety)
    • HUMAN HERPESVIRUS 6 (UNII: 4IX4VP35CR)
    • HUMAN HERPESVIRUS 6 (UNII: 4IX4VP35CR) (Active Moiety)
    • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K)
    • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K) (Active Moiety)
    • HEPATITIS B VIRUS (UNII: 77H9EM77P7)
    • HEPATITIS B VIRUS (UNII: 77H9EM77P7) (Active Moiety)
    • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN (UNII: FKD3DUK39I)
    • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 (UNII: FKD3DUK39I) (Active Moiety)
    • HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN (UNII: TM54L796SN)
    • HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN (UNII: TM54L796SN) (Active Moiety)
    • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX)
    • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (Active Moiety)

    Which are Virus Combination Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    Which are the Pharmacologic Classes for Virus Combination?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".